Clinical Trials Update: April 26, 2004

Ovarian Cancer Hot Flash Allergy

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Ovarian Cancer

A research study to determine the effectiveness of a combination of medications for the treatment of recurrent platinum-sensitive ovarian, fallopian or primary peritoneal cancer, as well as tumors of mixed mullerian origin. Female volunteers 18 or older who have had one prior platinum-based chemotherapy regimen for treatment of their primary disease may be eligible. Research site located in Lansing, Mich.

More information

Please see http://www.centerwatch.com/patient/studies/cat186.html.

-----

Hot Flash

A research study of an investigational topical gel medication to treat hot flashes. Volunteers who are postmenopausal, are in good general health, experience numerous hot flashes each day, and who have not used transdermal hormone products in the last four weeks may be eligible. Research site located in Pensacola, Fla.

More information

Please see http://www.centerwatch.com/patient/studies/cat309.html.

-----

Allergy

A research study of an investigational medication for the treatment of allergies. Volunteers 12 and older who have at least a two-year history of spring allergies may be eligible. Research site located in Arlington, Va.

More information

Please see http://www.centerwatch.com/patient/studies/cat166.html.

-----

Copyright 2004 CenterWatch. All rights reserved.

Related Stories

No stories found.
logo
www.healthday.com